These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 31451329)
1. Treatment of Membranous Nephropathy in Patients With THSD7A Antibodies Using Immunoadsorption. Weinmann-Menke J; Holtz S; Sollinger D; Dörken M; Boedecker S; Schamberger B; Pfister F; Amann K; Lutz J Am J Kidney Dis; 2019 Dec; 74(6):849-852. PubMed ID: 31451329 [TBL] [Abstract][Full Text] [Related]
2. Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy. Wang J; Cui Z; Lu J; Probst C; Zhang YM; Wang X; Qu Z; Wang F; Meng LQ; Cheng XY; Liu G; Debiec H; Ronco P; Zhao MH Clin J Am Soc Nephrol; 2017 Oct; 12(10):1642-1651. PubMed ID: 28801527 [TBL] [Abstract][Full Text] [Related]
3. VEGF-A Links Angiolymphoid Hyperplasia With Eosinophilia (ALHE) to THSD7A Membranous Nephropathy: A Report of 2 Cases. Matsumoto A; Matsui I; Namba T; Sakaguchi Y; Mizuno H; Shirayama Y; Shimada K; Hashimoto N; Doi Y; Yamaguchi S; Kubota K; Oka T; Mori D; Akiyama S; Hamano T; Mizui M; Takabatake Y; Kaneko T; Isaka Y Am J Kidney Dis; 2019 Jun; 73(6):880-885. PubMed ID: 30554801 [TBL] [Abstract][Full Text] [Related]
4. Thrombospondin type-1 domain-containing 7A-associated membranous nephropathy after resection of rectal cancer: a case report. Taguchi S; Koshikawa Y; Ohyama S; Miyachi H; Ozawa H; Asada H BMC Nephrol; 2019 Feb; 20(1):43. PubMed ID: 30727973 [TBL] [Abstract][Full Text] [Related]
5. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China. Zhang D; Zou J; Zhang C; Zhang W; Lin F; Jiang G Med Sci Monit; 2018 Jul; 24():5076-5083. PubMed ID: 30032157 [TBL] [Abstract][Full Text] [Related]
8. A Heterologous Model of Thrombospondin Type 1 Domain-Containing 7A-Associated Membranous Nephropathy. Tomas NM; Meyer-Schwesinger C; von Spiegel H; Kotb AM; Zahner G; Hoxha E; Helmchen U; Endlich N; Koch-Nolte F; Stahl RAK J Am Soc Nephrol; 2017 Nov; 28(11):3262-3277. PubMed ID: 28814510 [TBL] [Abstract][Full Text] [Related]
9. Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy. Zaghrini C; Seitz-Polski B; Justino J; Dolla G; Payré C; Jourde-Chiche N; Van de Logt AE; Booth C; Rigby E; Lonnbro-Widgren J; Nystrom J; Mariat C; Cui Z; Wetzels JFM; Ghiggeri G; Beck LH; Ronco P; Debiec H; Lambeau G Kidney Int; 2019 Mar; 95(3):666-679. PubMed ID: 30784662 [TBL] [Abstract][Full Text] [Related]
10. Characterization of THSD7A-antibodies not binding to glomerular THSD7A in a patient with diabetes mellitus but no membranous nephropathy. Reinhard L; Thomas C; Machalitza M; Lattwein E; Weiss LS; Vitu J; Wiech T; Stahl RAK; Hoxha E Sci Rep; 2021 Aug; 11(1):16188. PubMed ID: 34376704 [TBL] [Abstract][Full Text] [Related]
11. An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy. Hoxha E; Beck LH; Wiech T; Tomas NM; Probst C; Mindorf S; Meyer-Schwesinger C; Zahner G; Stahl PR; Schöpper R; Panzer U; Harendza S; Helmchen U; Salant DJ; Stahl RA J Am Soc Nephrol; 2017 Feb; 28(2):520-531. PubMed ID: 27436855 [TBL] [Abstract][Full Text] [Related]
12. Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy. von Haxthausen F; Reinhard L; Pinnschmidt HO; Rink M; Soave A; Hoxha E; Stahl RAK Front Immunol; 2018; 9():3035. PubMed ID: 30619370 [TBL] [Abstract][Full Text] [Related]
13. Membranous nephropathy associated with thrombospondin type-1 domain-containing 7A (THSD7A) in an adult woman with eosinophilia. Shirai S; Akiyama S; Kamijo-Ikemori A; Suzuki T; Ichikawa D; Koike J; Kimura K; Shibagaki Y CEN Case Rep; 2020 Feb; 9(1):65-73. PubMed ID: 31705303 [TBL] [Abstract][Full Text] [Related]
14. [Membranous glomerulonephritis : An example of individualized medicine in nephrology]. Stahl RAK; Hoxha E Internist (Berl); 2019 May; 60(5):440-449. PubMed ID: 30859275 [TBL] [Abstract][Full Text] [Related]
15. Human anti-thrombospondin type 1 domain-containing 7A antibodies induce membranous nephropathy through activation of lectin complement pathway. Wang Z; Wen L; Dou Y; Zhao Z Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29769410 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of M Gong Z; Yuan S; Zhu X; Wang Y; Yu F; Yang D; Xu X; Liu H; Li J; Sun L Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 45(6):693-700. PubMed ID: 32879127 [TBL] [Abstract][Full Text] [Related]
17. The Most N-Terminal Region of THSD7A Is the Predominant Target for Autoimmunity in THSD7A-Associated Membranous Nephropathy. Seifert L; Hoxha E; Eichhoff AM; Zahner G; Dehde S; Reinhard L; Koch-Nolte F; Stahl RAK; Tomas NM J Am Soc Nephrol; 2018 May; 29(5):1536-1548. PubMed ID: 29555830 [No Abstract] [Full Text] [Related]
18. Duodenal Schwannoma as a Rare Association With Membranous Nephropathy: A Case Report. Zhang Z; Gong T; Rennke HG; Hayashi R Am J Kidney Dis; 2019 Feb; 73(2):278-280. PubMed ID: 30454884 [TBL] [Abstract][Full Text] [Related]
19. [Clinical Significance of Thrombospondin Type 1 Domain-Containing 7A and Neural Epidermal Growth Factor-Like 1 Protein in M-Type Phospholipase A2 Receptor-Negative Membranous Nephropathy]. Tang XL; DU YY; Yu J; Ye T; Zhu H; Chen YF; Li XH Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Apr; 45(2):235-244. PubMed ID: 37157070 [TBL] [Abstract][Full Text] [Related]
20. A rare case of PLA2R- and THSD7A-positive idiopathic membranous nephropathy. Wanderley DC; Jones BD; Barbosa FAM; Araujo SA J Bras Nefrol; 2019 Oct; 42(2):254-258. PubMed ID: 31663595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]